Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Nov 22;16(1):165.
doi: 10.1186/s11671-021-03608-w.

Down-regulation of microRNA-342-5p or Up-regulation of Wnt3a Inhibits Angiogenesis and Maintains Atherosclerotic Plaque Stability in Atherosclerosis Mice

Affiliations

Down-regulation of microRNA-342-5p or Up-regulation of Wnt3a Inhibits Angiogenesis and Maintains Atherosclerotic Plaque Stability in Atherosclerosis Mice

Haixia Sun et al. Nanoscale Res Lett. .

Retraction in

Abstract

Evidence has demonstrated that microRNA-342-5p (miR-342-5p) is implicated in atherosclerosis (AS), but little is known regarding its intrinsic regulatory mechanisms. Here, we aimed to explore the effect of miR-342-5p targeting Wnt3a on formation of vulnerable plaques and angiogenesis of AS. ApoE-/- mice were fed with high-fat feed for 16 w to replicate the AS vulnerable plaque model. miR-342-5p and Wnt3a expression in aortic tissues of AS were detected. The target relationship between miR-342-5p and Wnt3a was verified. Moreover, ApoE-/- mice were injected with miR-342-5p antagomir and overexpression-Wnt3a vector to test their functions in serum lipid levels, inflammatory and oxidative stress-related cytokines, aortic plaque stability and angiogenesis in plaque of AS mice. miR-342-5p expression was enhanced and Wnt3a expression was degraded in aortic tissues of AS mice and miR-342-5p directly targeted Wnt3a. Up-regulating Wnt3a or down-regulating miR-342-5p reduced blood lipid content, inflammatory and oxidative stress levels, the vulnerability of aortic tissue plaque and inhibited angiogenesis in aortic plaque of AS mice. Functional studies show that depleting miR-342-5p can stabilize aortic tissue plaque and reduce angiogenesis in plaque in AS mice via restoring Wnt3a.

Keywords: Atherosclerosis; MicroRNA-342-5p; Microvessel density; Vulnerability index; Vulnerable plaque; Wnt3a.

PubMed Disclaimer

Conflict of interest statement

The authors have no conflicts of interest to declare that are relevant to the content of this article.

Figures

Fig. 1
Fig. 1
miR-342-5p increases and Wnt3a decreases in aortic tissues of ApoE−/− mice and miR-342-5p directly targets Wnt3a. A Expression of miR-342-5p in aortic tissue of mice detected by RT-qPCR. B Expression of Wnt3a mRNA in aortic tissue of mice detected by RT-qPCR (n = 12). C, D Wnt3a and β-catenin protein expression in aortic tissues of mice tested by Western blot analysis (n = 12). E Binding site of miR-342-5p within Wnt3a 3′-UTR. F miR-342-5p agomir dose-dependently decreased the relative activity in cells transfected with Wnt3a 3′-UTR (N = 3). G Relative activity of luciferase in cells with wild-type and mutant Wnt3a 3′-UTR after transfected with miR-342-5p agomir or scramble (N = 3). *P < 0.05 vs. the normal group, #P < 0.05 vs. the NC group. & P < 0.05 vs. the miR-342-5p agomir group. Measurement data were indicated as mean ± standard deviation. Comparisons between two groups were formulated by t-test, while comparisons among multiple groups were assessed by one-way ANOVA followed by Tukey’s multiple comparisons test. AS, atherosclerosis; NC, negative control
Fig. 2
Fig. 2
Effects of up-regulated Wnt3a or down-regulated miR-342-5p on the lipid levels in ApoE−/− mice. A Comparison of HDL-C contents in serum of mice group. B Comparison of LDL-C contents in serum of mice group. C Comparison of TG contents in serum of mice group. D Comparison of TC contents in serum of mice group. n = 12. *P < 0.05 vs. the normal group, #P < 0.05 vs. the NC group. & P < 0.05 vs. the miR-342-5p agomir group. Measurement data were indicated as mean ± standard deviation. Comparisons among multiple groups were assessed by one-way ANOVA followed by Tukey’s multiple comparisons test. AS, atherosclerosis; NC, negative control
Fig. 3
Fig. 3
Effects of overexpression of Wnt3a or low expression of miR-342-5p on inflammatory and oxidative stress-related cytokines in serum of ApoE−/− mice. A Comparison of IL-5 contents in serum of mice group. B Comparison of IL-12p70 contents in serum of mice group. C Comparison of IFN-γ contents in serum of mice group. D Comparison of TNF-α contents in serum of mice group. E, Comparison of MDA content in serum of mice group. F Comparison of SOD activity in serum of mice group. n = 12. *P < 0.05 vs. the normal group, #P < 0.05 vs. the NC group. & P < 0.05 vs. the miR-342-5p agomir group. Measurement data were indicated as mean ± standard deviation. Comparisons among multiple groups were assessed by one-way ANOVA followed by Tukey’s multiple comparisons test. AS, atherosclerosis; NC, negative control
Fig. 4
Fig. 4
Effects of depletion of miR-342-5p or restoration of Wnt3a on lipid and collagen content in aortic plaque of ApoE−/− mice. A Results of aortic HE staining in mice (scale bar: 50 μm). B Comparison of aortic plaque area in each group of mice. C Results of aortic Oil Red O staining in all groups of mice (scale bar: 100 μm). D Comparison of lipid content in aortic tissue of mice. E Results of aortic Sirius red staining in each group of mice (scale bar: 50 μm). F Comparison of collagen contents in aortic tissues of mice. n = 12. #P < 0.05 vs. the NC group. & P < 0.05 vs. the miR-342-5p agomir group. Measurement data were indicated as mean ± standard deviation. Comparisons among multiple groups were assessed by one-way ANOVA followed by Tukey’s multiple comparisons test. AS, atherosclerosis; NC, negative control
Fig. 5
Fig. 5
Effects of high expression of Wnt3a or poor expression of miR-342-5p on aortic plaque vulnerability of ApoE−/− mice. A Immunohistochemical staining of MOMA-2 in each group of mice (scale bar: 50 μm). B Quantitative analysis of figure A. C Immunohistochemical staining of α-SMA in each group of mice (scale bar: 50 μm). D Quantitative analysis of figure C. E Comparison of plaque vulnerability index in aortic tissues of AS mice. n = 12. #P < 0.05 vs. the NC group. & P < 0.05 vs. the miR-342-5p agomir group. Measurement data were indicated as mean ± standard deviation. Comparisons among multiple groups were assessed by one-way ANOVA followed by Tukey’s multiple comparisons test. AS, atherosclerosis; NC, negative control
Fig. 6
Fig. 6
Effects of low expression of miR-342-5p or overexpression of Wnt3a on MVD in aortic plaque of ApoE−/− mice. A Immunohistochemical staining of CD34 in each group of ApoE−/− mice (scale bar: 50 μm). B Comparison of MVD in aortic plaque in ApoE−/− mice. C Comparison of CD34 protein expression in ApoE−/− mice. n = 12. #P < 0.05 vs. the NC group. & P < 0.05 vs. the miR-342-5p agomir group. Measurement data were indicated as mean ± standard deviation. Comparisons among multiple groups were assessed by one-way ANOVA followed by Tukey’s multiple comparisons test. AS, atherosclerosis; NC, negative control

References

    1. Han Z, Guan Y, Liu B, et al. MicroRNA-99a-5p alleviates atherosclerosis via regulating Homeobox A1. Life Sci. 2019;232:116664. doi: 10.1016/j.lfs.2019.116664. - DOI - PubMed
    1. Yilmaz SG, Isbir S, Kunt AT, Isbir T. Circulating microRNAs as novel biomarkers for atherosclerosis. In Vivo. 2018;32(3):561–565. - PMC - PubMed
    1. Di Gregoli K, Jenkins N, Salter R, White S, Newby AC, Johnson JL. MicroRNA-24 regulates macrophage behavior and retards atherosclerosis. Arterioscler Thromb Vasc Biol. 2014;34(9):1990–2000. doi: 10.1161/ATVBAHA.114.304088. - DOI - PubMed
    1. Yang Y, Yang L, Liang X, Zhu G. MicroRNA-155 Promotes Atherosclerosis Inflammation via targeting SOCS1. Cell Physiol Biochem. 2015;36(4):1371–1381. doi: 10.1159/000430303. - DOI - PubMed
    1. Liu M, Tao G, Liu Q, Liu K, Yang X. MicroRNA let-7g alleviates atherosclerosis via the targeting of LOX-1 in vitro and in vivo. Int J Mol Med. 2017;40(1):57–64. doi: 10.3892/ijmm.2017.2995. - DOI - PMC - PubMed

Publication types